Importantly, distinct G protein signalling is associated with the alleviation of symptoms in hypoglutamatergic models of schizophrenia, with preferential Gq-acting ligands such as CHA proving more efficacious, indicating the functional and therapeutic utility of these novel insights into TAAR1-G protein signalling (34, 70). Here, TAAR1 is linked to schizophrenia.